Similar articles

• Proceedings of the 16th IRIST Congress 2003: Peptide Radiopharmaceuticals in Diagnosis and Therapy of Cancer and Inflammation/Infection. May 8-10, 2003, Isle of Capri, Italy.

  [No authors listed] [No authors listed] Cancer Biother Radiopharm. 2004 Apr;19(2):173-270. Cancer Biother Radiopharm. 2004. PMID: 15584147 No abstract available.
• Peptide radiopharmaceuticals for diagnosis and therapy.

  Signore A, Annovazzi A, Chianelli M, Corsetti F, Van de Wiele C, Watherhouse RN. Signore A, et al. Eur J Nucl Med. 2001 Oct;28(10):1555-65. doi: 10.1007/s002590100583. Epub 2001 Jul 31. Eur J Nucl Med. 2001. PMID: 11685500 Review.
• Radiolabelling of peptides for diagnosis and therapy of non-oncological diseases.

  Sosabowsky J, Melendez-Alafort L, Mather S. Sosabowsky J, et al. Q J Nucl Med. 2003 Dec;47(4):223-37. Q J Nucl Med. 2003. PMID: 14973415 Review.
• Rationale for the use of radiolabelled peptides in diagnosis and therapy.

  Koopmans KP, Glaudemans AW. Koopmans KP, et al. Eur J Nucl Med Mol Imaging. 2012 Feb;39 Suppl 1:S4-10. doi: 10.1007/s00259-011-2038-z. Eur J Nucl Med Mol Imaging. 2012. PMID: 22388630 Review.
• Radiolabeled peptides in diagnosis and therapy.

  Weiner RE, Thakur ML. Weiner RE, et al. Semin Nucl Med. 2001 Oct;31(4):296-311. doi: 10.1053/snuc.2001.27045. Semin Nucl Med. 2001. PMID: 11710772 Review.